Project Grant R03HD121842
- Project Grant Summary The University of Massachusetts received a $436,628 Project Grant awarded on May 25, 2026, by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The project, concluding April 30, 2028, focuses on defining the dynamics and regulation of calcium/calmodulin-dependent protein kinase II (CaMKII), specifically the CaMKIIγ variant essential for mammalian egg activation. The...
- Federal Grant Award Summary The University of Massachusetts received a $478,453 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective September 1, 2026 through May 31, 2031. This award supports large-scale analysis of early lethal phenotypes generated through the International Mouse Phenotyping Consortium (IMPC) and Knockout Mouse Project (KOMP) initiatives. The...
- Federal Project Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded the University of Massachusetts Medical School $460,625 under the Child Health and Human Development Extramural Research program (CFDA 93.865) on June 1, 2026, with completion targeted for May 31, 2028. This project grant supports the development of prime editing therapeutics for Limb Girdle Muscular Dystrophy R9 (LGMDR9), a rare genetic disorder caused by mutations in the FKRP...
- Federal Grant Award Summary Massachusetts General Hospital received a $1.17 million Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded September 1, 2025, with a completion date of May 31, 2030. The project aims to validate and optimize Non-Invasive Fetal Sequencing (NIFS), a high-resolution prenatal genetic screening technology capable of conducting unbiased...
- This federal Project Grant award for $378,123 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports research to identify and test mechanisms that establish transcriptional regulatory potency in early embryos. The primary activities include using genomic methods like PRO-seq, DREG, and OMNI-ATAC to characterize transcriptionally active regulatory elements, DNA accessibility, and...
- Federal Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded a $730,972 Project Grant to Massachusetts General Hospital under the Child Health and Human Development Extramural Research program (CFDA 93.865) for the period June 1, 2026 through February 28, 2031. The grant supports research to develop novel small-molecule anti-Mullerian hormone receptor 2 (AMHR2) agonists as a new class of female contraceptives. The research addresses limitations of...
- Federal Project Grant Award Summary The University of Kansas Medical Center Research Institute, Inc. received a $426,250 Project Grant award dated August 6, 2025, from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award supports research through July 31, 2027, investigating the role of Protein Arginine Methyltransferase 1 (PRMT1) in regulating trophoblast development and...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $682,848 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective June 1, 2026, with a completion date of February 28, 2031. The award supports research investigating mitochondrial function in germ cell development through a novel enforced mitophagy platform. The research...
- Federal Project Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded Massachusetts General Hospital $170,640 on August 1, 2025, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to support a five-year research project examining the role of the fibroblast growth factor receptor 1 (FGFR1) signaling pathway in the intersection of reproduction and metabolism. The research will elucidate how distinct fibroblast growth...
- Federal Project Grant Award Summary The University of Pennsylvania received a $995,378 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded August 14, 2025, with completion targeted for May 31, 2030. This award supports investigator-initiated research examining the role of actin in ensuring mitotic fidelity during early mammalian development. The research employs...
This Project Grant, awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), funds investigator-initiated research examining the role of maternal MCM4 protein in early mammalian embryonic development. The University of Massachusetts received $157,427 in obligated funding for the project period from May 25, 2026 through April 30, 2028. The research deliverables include scientific investigations using live imaging, immunofluorescence microscopy, and RNA-sequencing analyses to characterize how maternal MCM4 (a core component of the MCM2-7 DNA replication helicase complex) governs zygotic DNA replication fidelity and mitotic progression during the oocyte-to-embryo transition. The project will generate novel insights into maternal control mechanisms during early embryonic development and will produce scientific data and analysis addressing critical gaps in understanding cell cycle regulation, checkpoint control, and chromatin dynamics in replication-deficient conditions. Research outcomes may contribute to advancing understanding of developmental arrest, infertility, and early embryonic loss—areas of significant relevance to the NICHD's mission of improving reproductive health and enhancing outcomes across the lifespan. The work will be conducted at the University of Massachusetts facility in Hadley, Massachusetts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $157.4k | 5/20/26 |